Overview
Succinyl-CoA Ligase GDP-forming subunit alpha (SUCLG1) is a mitochondrial enzyme that catalyzes a critical step in the citric acid cycle and nucleotide metabolism. Also known as succinyl-CoA synthetase alpha subunit, this protein is encoded by the SUCLG1 gene located on chromosome 2 in humans. SUCLG1 functions as part of a heterodimeric enzyme complex with SUCLG2 (the beta subunit) to catalyze the reversible conversion of succinyl-CoA and GDP (or ADP) into succinate and GTP (or ATP). This reaction represents the only substrate-level phosphorylation step in the citric acid cycle, making it essential for both energy production and metabolic regulation. The protein is predominantly localized to mitochondrial matrix, where it interfaces with multiple cellular pathways including energy metabolism, biosynthesis, and cell signaling.
Function/Biology
SUCLG1 catalyzes the nucleotidyl-transfer reaction: Succinyl-CoA + GDP (or ADP) + Pi ⇌ Succinate + GTP (or ATP) + CoA. The enzyme functions as the alpha/catalytic subunit of the succinyl-CoA ligase complex, with tissue-specific activity patterns determined by subunit composition. In most tissues, SUCLG1 preferentially uses GDP as substrate, generating GTP that can be rapidly converted to ATP through nucleoside-diphosphate kinase. The reaction is thermodynamically favorable under physiological conditions and represents a key control point in the citric acid cycle.
...Overview
Succinyl-CoA Ligase GDP-forming subunit alpha (SUCLG1) is a mitochondrial enzyme that catalyzes a critical step in the citric acid cycle and nucleotide metabolism. Also known as succinyl-CoA synthetase alpha subunit, this protein is encoded by the SUCLG1 gene located on chromosome 2 in humans. SUCLG1 functions as part of a heterodimeric enzyme complex with SUCLG2 (the beta subunit) to catalyze the reversible conversion of succinyl-CoA and GDP (or ADP) into succinate and GTP (or ATP). This reaction represents the only substrate-level phosphorylation step in the citric acid cycle, making it essential for both energy production and metabolic regulation. The protein is predominantly localized to mitochondrial matrix, where it interfaces with multiple cellular pathways including energy metabolism, biosynthesis, and cell signaling.
Function/Biology
SUCLG1 catalyzes the nucleotidyl-transfer reaction: Succinyl-CoA + GDP (or ADP) + Pi ⇌ Succinate + GTP (or ATP) + CoA. The enzyme functions as the alpha/catalytic subunit of the succinyl-CoA ligase complex, with tissue-specific activity patterns determined by subunit composition. In most tissues, SUCLG1 preferentially uses GDP as substrate, generating GTP that can be rapidly converted to ATP through nucleoside-diphosphate kinase. The reaction is thermodynamically favorable under physiological conditions and represents a key control point in the citric acid cycle.
SUCLG1 expression varies across tissues, with highest levels in mitochondria-dense organs including brain, heart, and liver. The protein undergoes post-translational modifications including phosphorylation and acetylation that regulate its activity and localization. The enzyme's activity is tightly regulated by allosteric effectors—particularly inhibited by high ATP/ADP and GTP/GDP ratios, creating a negative feedback mechanism that prevents excess nucleotide synthesis when energy is abundant.
Role in Neurodegeneration
SUCLG1 dysfunction has emerged as a significant factor in multiple neurodegenerative diseases. Mutations in SUCLG1 cause autosomal dominant progressive external ophthalmoplegia (adPEO), a mitochondrial disorder characterized by progressive eye movement paralysis and often accompanied by progressive neuromuscular weakness and cognitive decline. These pathogenic variants impair the enzyme's catalytic efficiency or stability, compromising energy production in highly active neurons.
Reduced SUCLG1 activity impairs the citric acid cycle's functioning, leading to decreased ATP production precisely when neurons require maximum energy availability for synaptic transmission and axonal transport. This energy deficit particularly affects neurons with high metabolic demands, such as motor neurons and neurons involved in executive function. Furthermore, impaired succinyl-CoA ligase activity disrupts the balance of citric acid cycle intermediates, potentially affecting multiple downstream metabolic pathways including amino acid synthesis, heme biosynthesis, and immune regulation.
Secondary SUCLG1 dysfunction may contribute to sporadic neurodegenerative diseases including Alzheimer's disease and Parkinson's disease, where mitochondrial energy metabolism is compromised. Reduced citric acid cycle flux and ATP deficiency could exacerbate pathological processes including amyloid-beta accumulation, tau phosphorylation, and alpha-synuclein aggregation.
Molecular Mechanisms
SUCLG1 mutations associated with adPEO typically impair enzyme kinetics or promote protein instability. Pathogenic variants affect residues critical for nucleotide binding, CoA recognition, or subunit interaction with SUCLG2. These changes reduce Vmax or increase Km values, diminishing catalytic efficiency. Defective SUCLG1 reduces GTP/ATP production from the citric acid cycle, particularly affecting tissues with high oxidative metabolism.
Impaired SUCLG1 function triggers mitochondrial stress responses, including activation of AMPK signaling when ATP levels decline, increased oxidative stress from electron transport chain dysfunction, and potential mitophagy of damaged mitochondria. Neuronal axons become particularly vulnerable due to their limited capacity for alternative ATP generation and dependence on oxidative phosphorylation.
Clinical/Research Significance
SUCLG1 mutations represent an identifiable genetic cause of progressive external ophthalmoplegia, with therapeutic implications. Understanding SUCLG1 dysfunction illuminates energy metabolism's role in neurodegeneration more broadly. Research into SUCLG1 may identify biomarkers for detecting mitochondrial dysfunction in neurodegenerative diseases and reveal therapeutic targets for enhancing energy production in energy-deficient neurons.
- SUCLG2: Beta subunit of succinyl-CoA ligase forming the catalytically active heterodimer
- Citric Acid Cycle: Metabolic pathway containing the SUCLG1-catalyzed reaction
- Mitochondrial DNA: Subject to mutation-induced instability from impaired SUCLG1 function
- ATP Synthase: Downstream